These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12780752)

  • 21. Sex-related alterations in hypothalamic growth hormone-releasing hormone mRNA-but not somatostatin mRNA-expressing cells in genetically obese Zucker rats.
    Tannenbaum GS; Epelbaum J; Videau C; Dubuis JM
    Neuroendocrinology; 1996 Sep; 64(3):186-93. PubMed ID: 8875436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome.
    Di Giorgio G; Grugni G; Fintini D; Bocchini S; Spera S; Cuttini M; Cappa M; Crinò A
    Horm Res Paediatr; 2014; 81(3):189-95. PubMed ID: 24503962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucagon stimulation test to assess growth hormone status in Prader-Willi syndrome.
    Casamitjana L; Giménez-Palop O; Corripio R; Pareja R; Berlanga E; Rigla M; Oliva JC; Caixàs A
    J Endocrinol Invest; 2021 Mar; 44(3):621-629. PubMed ID: 32720093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating insulin-like growth factor 1 levels are reduced in very young children with Prader-Willi syndrome independent of anthropometric parameters and nutritional status.
    Koizumi M; Konishi A; Etani Y; Ida S; Kawai M
    Clin Endocrinol (Oxf); 2022 Mar; 96(3):346-352. PubMed ID: 34750859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal treatment with monosodium glutamate: effects of prolonged growth hormone (GH)-releasing hormone deficiency on pulsatile GH secretion and growth in female rats.
    Maiter D; Underwood LE; Martin JB; Koenig JI
    Endocrinology; 1991 Feb; 128(2):1100-6. PubMed ID: 1989848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The GH/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome.
    van Nieuwpoort IC; Sinnema M; Castelijns JA; Twisk JW; Curfs LM; Drent ML
    Horm Res Paediatr; 2011; 75(6):403-11. PubMed ID: 21273761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.
    Cadoudal T; Buléon M; Sengenès C; Diene G; Desneulin F; Molinas C; Eddiry S; Conte-Auriol F; Daviaud D; Martin PG; Bouloumié A; Salles JP; Tauber M; Valet P
    Int J Obes (Lond); 2014 Sep; 38(9):1234-40. PubMed ID: 24406482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
    Growth Horm IGF Res; 2010 Jun; 20(3):179-84. PubMed ID: 20199883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there growth hormone deficiency in prader-willi Syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome.
    Eiholzer U; Bachmann S; l'Allemand D
    Horm Res; 2000; 53 Suppl 3():44-52. PubMed ID: 10971104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome.
    Priano L; Grugni G; Miscio G; Guastamacchia G; Toffolet L; Sartorio A; Mauro A
    Sleep Med; 2006 Dec; 7(8):627-33. PubMed ID: 17023209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Growth failure in Prader-Willi syndrome is secondary to growth hormone deficiency.
    Thacker MJ; Hainline B; St Dennis-Feezle L; Johnson NB; Pescovitz OH
    Horm Res; 1998; 49(5):216-20. PubMed ID: 9568805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes.
    Grugni G; Giardino D; Crinò A; Malvestiti F; Ballarati L; Di Giorgio G; Marzullo P
    J Endocrinol Invest; 2011; 34(7):493-7. PubMed ID: 20651469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P; Isidro L; Leal-Cerro A; Casanueva FF; Dieguez C; Cordido F
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome.
    Burnett LC; LeDuc CA; Sulsona CR; Paull D; Rausch R; Eddiry S; Carli JF; Morabito MV; Skowronski AA; Hubner G; Zimmer M; Wang L; Day R; Levy B; Fennoy I; Dubern B; Poitou C; Clement K; Butler MG; Rosenbaum M; Salles JP; Tauber M; Driscoll DJ; Egli D; Leibel RL
    J Clin Invest; 2017 Jan; 127(1):293-305. PubMed ID: 27941249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperghrelinemia is a common feature of Prader-Willi syndrome and pituitary stalk interruption: a pathophysiological hypothesis.
    Tauber M; Conte Auriol F; Moulin P; Molinas C; Delagnes V; Salles JP
    Horm Res; 2004; 62(1):49-54. PubMed ID: 15192277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.